Kodiak Sciences Inc.
(KOD - NASDAQ)
44,11 USD
📋 Profilo Aziendale

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases.

|